Tandem high dose chemotherapy and myeloablative radioimmunotherapy with 131-I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Interim results of a phase II study of the German RIT study group

ISSN
0923-7534
Date Issued
2005
Author(s)
Glass, Bertram
Jung, Werner
Stitz, E.
Griesinger, Frank